Does voluntary assisted dying cause public stigma for the bereaved? A vignette-based experiment.


Journal

Palliative & supportive care
ISSN: 1478-9523
Titre abrégé: Palliat Support Care
Pays: England
ID NLM: 101232529

Informations de publication

Date de publication:
10 2021
Historique:
pubmed: 6 1 2021
medline: 1 2 2022
entrez: 5 1 2021
Statut: ppublish

Résumé

Studies in countries where assisted dying is legal show that bereaved people express concern over the potential for social disapproval and social stigma because of the manner of death. There are indications that voluntary assisted dying is judged as less acceptable if the deceased is younger. A vignette-based experiment was used to determine whether public stigma (i.e., negative emotional reactions and desired social distance) and expected grief symptoms are higher for conjugally bereaved people through voluntary assisted dying (vs. long-term illness), when the deceased is a young adult (vs. older adult). A 2 × 2 randomized factorial design was conducted with 164 Australian adults (130 women, 34 men, Mage = 37.69 years). Each participant was randomized online to read one of four vignettes and completed measures of anger, fear, prosocial emotions, desire for social distance, and expectations of grief symptomatology. A multivariate analysis of variance (MANOVA) was conducted. Death at a young age (28 years) was significantly associated with stronger negative emotional reactions of fear ($\eta _p^2 = 0.04$, P = 0.048) and anger ($\eta _p^2 = 0.06$, P = 0.010). There were no differences in outcomes associated with the mode of death, nor was there an interaction between mode of death and age group. Concerns that voluntary assisted dying elicits public stigma appear unfounded. The fact that participants reported significantly higher anger and fear in response to bereaved people experiencing loss at a younger (vs. older) age, irrespective of cause of death, indicates that young people who lose their spouse might benefit from additional support.

Identifiants

pubmed: 33397540
doi: 10.1017/S1478951520001352
pii: S1478951520001352
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

558-562

Auteurs

Sarah Philippkowski (S)

School of Psychology, Curtin University, Perth, WA6102, Australia.

Moira O'Connor (M)

School of Psychology, Curtin University, Perth, WA6102, Australia.
WA Cancer Prevention Research Institute (WACPRU), School of Psychology, Perth, WA6102, Australia.

Maarten C Eisma (MC)

Faculty of Behavioural and Social Sciences, University of Groningen, Groningen, 9701, The Netherlands.

Lindy Willmott (L)

Faculty of Law, Queensland University of Technology, Brisbane, QLD4000, Australia.

Andrew R Johnson (AR)

School of Psychology, Curtin University, Perth, WA6102, Australia.

Lauren J Breen (LJ)

School of Psychology, Curtin University, Perth, WA6102, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH